173 related articles for article (PubMed ID: 38521531)
21. The triglyceride-glucose index and contrast-induced nephropathy in non-ST elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Gursoy E; Baydar O
Medicine (Baltimore); 2023 Jan; 102(2):e32629. PubMed ID: 36637929
[TBL] [Abstract][Full Text] [Related]
22. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
[TBL] [Abstract][Full Text] [Related]
23. Triglyceride-glucose index impact on in-hospital mortality in acute myocardial infarction. Results from the RECUIMA multicenter registry.
Martínez-García G; Rodríguez-Ramos M; Santos-Medina M; Mata-Cuevas LA; Carrero-Vázquez AM; Chipi-Rodríguez Y
Gac Med Mex; 2022; 158(2):83-89. PubMed ID: 35763827
[TBL] [Abstract][Full Text] [Related]
24. Relationship between TyG index and the degree of coronary artery lesions in patients with H-type hypertension.
Xu Z; Chen P; Wang L; Yan J; Yan X; Li D
Cardiovasc Diabetol; 2024 Jan; 23(1):23. PubMed ID: 38216931
[TBL] [Abstract][Full Text] [Related]
25. Association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute coronary syndrome: results from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome project.
Wang W; Yang J; Wang K; Niu J; Liu Y; Ge H;
Cardiovasc Diabetol; 2024 May; 23(1):170. PubMed ID: 38750553
[TBL] [Abstract][Full Text] [Related]
26. Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.
Wang Y; Wang W; Jia S; Gao M; Zheng S; Wang J; Dang Y; Li Y; Qi X
BMJ Open; 2022 Feb; 12(2):e056101. PubMed ID: 35110324
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
[TBL] [Abstract][Full Text] [Related]
28. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Ying C; Liu CF; Guo DQ; Du ZR; Wei YJ
Clinics (Sao Paulo); 2023; 78():100306. PubMed ID: 37949037
[TBL] [Abstract][Full Text] [Related]
29. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
Guo X; Shen R; Yan S; Su Y; Ma L
Cardiovasc Diabetol; 2023 Mar; 22(1):43. PubMed ID: 36864455
[TBL] [Abstract][Full Text] [Related]
30. Association between triglyceride glucose index and adverse clinical outcomes in patients with acute myocardial infarction and LDL-C≤1.8 mmol/L who underwent percutaneous coronary intervention: a prospective cohort study.
Zhao HW; Wang Y; Wang CF; Meng QK
Front Endocrinol (Lausanne); 2023; 14():1323615. PubMed ID: 38313836
[TBL] [Abstract][Full Text] [Related]
31. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
[TBL] [Abstract][Full Text] [Related]
32. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.
Fu WX; Zhou TN; Wang XZ; Zhang L; Jing QM; Han YL
Chin Med J (Engl); 2018 Jun; 131(12):1420-1429. PubMed ID: 29893358
[TBL] [Abstract][Full Text] [Related]
33. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
34. A Combined Measure of the Triglyceride Glucose Index and Trimethylamine N-Oxide in Risk Stratification of ST-Segment Elevation Myocardial Infarction Patients with High-Risk Plaque Features Defined by Optical Coherence Tomography: A Substudy of the OCTAMI Registry Study.
Zhao X; Zhao H; Chen R; Li J; Zhou J; Li N; Yan S; Liu C; Zhou P; Chen Y; Song L; Yan H
Vasc Health Risk Manag; 2024; 20():141-155. PubMed ID: 38567028
[TBL] [Abstract][Full Text] [Related]
35. Association of systemic inflammatory response index with ST segment elevation myocardial infarction and degree of coronary stenosis: a cross-sectional study.
Guo J; Huang Y; Pang L; Zhou Y; Yuan J; Zhou B; Fu M
BMC Cardiovasc Disord; 2024 Feb; 24(1):98. PubMed ID: 38336634
[TBL] [Abstract][Full Text] [Related]
36. The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome.
Mao Q; Zhou D; Li Y; Wang Y; Xu SC; Zhao XH
Dis Markers; 2019; 2019():6891537. PubMed ID: 31281548
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention.
Sun T; Huang X; Zhang B; Ma M; Chen Z; Zhao Z; Zhou Y
Front Endocrinol (Lausanne); 2023; 14():1100399. PubMed ID: 36814584
[TBL] [Abstract][Full Text] [Related]
38. Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
Fukutomi M; Toriumi S; Ogoyama Y; Oba Y; Takahashi M; Funayama H; Kario K
Catheter Cardiovasc Interv; 2019 Apr; 93(5):E262-E268. PubMed ID: 30244539
[TBL] [Abstract][Full Text] [Related]
39. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study.
Cheng Y; Fang Z; Zhang X; Wen Y; Lu J; He S; Xu B
Cardiovasc Diabetol; 2023 Mar; 22(1):75. PubMed ID: 36997935
[TBL] [Abstract][Full Text] [Related]
40. Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study.
Zhao X; Song L; Li J; Zhou J; Li N; Yan S; Chen R; Wang Y; Liu C; Zhou P; Sheng Z; Chen Y; Zhao H; Yan H
J Inflamm Res; 2023; 16():269-282. PubMed ID: 36713050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
